TrialThe AAPS journal2018

Population Pharmacokinetics of AL-335 and Its Two Main Metabolites (ALS-022399, ALS-022227) in Monotherapy and in Combination with Odalasvir and/or Simeprevir.

Elodie Valade et al.PubMed ↗Publisher ↗

No numbers read from the abstract.